Regent Peak Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Regent Peak Wealth Advisors's PFE Position: Q4 2024 in Review
Regent Peak Wealth Advisors sold out of Pfizer (PFE) in Q4 2024, closing a stake of 6,938 shares — an estimated $201K sold.
Regent Peak Wealth Advisors first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $852K in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Regent Peak Wealth Advisors reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- Regent Peak Wealth Advisors sold 6,938 Pfizer shares in Q4 2024, an estimated $201K.
- Regent Peak Wealth Advisors first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
- Regent Peak Wealth Advisors's Pfizer position peaked at $852K in Q4 2021.
- 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Regent Peak Wealth Advisors's 13F filing for Q4 2024, filed 7 Jan 2025.